Matthew Bryant

3.8k total citations
76 papers, 2.5k citations indexed

About

Matthew Bryant is a scholar working on Molecular Biology, Cancer Research and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Matthew Bryant has authored 76 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 16 papers in Cancer Research and 13 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Matthew Bryant's work include Carcinogens and Genotoxicity Assessment (14 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Analytical Chemistry and Chromatography (8 papers). Matthew Bryant is often cited by papers focused on Carcinogens and Genotoxicity Assessment (14 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Analytical Chemistry and Chromatography (8 papers). Matthew Bryant collaborates with scholars based in United States, United Kingdom and China. Matthew Bryant's co-authors include Paul L. Skipper, Steven R. Tannenbaum, Malcolm Maclure, S R Tannenbaum, Qiangen Wu, Paolo Vineis, Kelly J. Davis, Walter A. Korfmacher, W.G. Stillwell and John S. Wishnok and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Public Health and Environmental Health Perspectives.

In The Last Decade

Matthew Bryant

75 papers receiving 2.3k citations

Peers

Matthew Bryant
Gunnar Boysen United States
P. B. Farmer United Kingdom
Henry d’A. Heck United States
G.A.S. Ansari United States
Alan M. Jeffrey United States
Glenn Talaska United States
Douglas E. Rickert United States
Seon Hwa Lee South Korea
Gunnar Boysen United States
Matthew Bryant
Citations per year, relative to Matthew Bryant Matthew Bryant (= 1×) peers Gunnar Boysen

Countries citing papers authored by Matthew Bryant

Since Specialization
Citations

This map shows the geographic impact of Matthew Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Bryant more than expected).

Fields of papers citing papers by Matthew Bryant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Bryant. The network helps show where Matthew Bryant may publish in the future.

Co-authorship network of co-authors of Matthew Bryant

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Bryant. A scholar is included among the top collaborators of Matthew Bryant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Bryant. Matthew Bryant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Si, Yuxi Li, Xilin Li, et al.. (2025). Mechanistic study of pexidartinib-induced toxicity in human hepatic cells. Chemico-Biological Interactions. 419. 111641–111641.
2.
Faske, Jennifer, et al.. (2024). CarcSeq detection of lorcaserin-induced clonal expansion ofPik3caH1047R mutants in rat mammary tissue. Toxicological Sciences. 201(1). 129–144. 3 indexed citations
3.
Inselman, Amy L., Elysia A. Masters, Rajiv Agarwal, et al.. (2024). The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model. Frontiers in Pharmacology. 15. 1365151–1365151. 1 indexed citations
4.
Chen, Si, Xilin Li, Yuxi Li, et al.. (2023). The involvement of hepatic cytochrome P450s in the cytotoxicity of lapatinib. Toxicological Sciences. 197(1). 69–78. 10 indexed citations
5.
Kwee, Brian J., Miao Li, Xiaobo He, et al.. (2023). Evaluation of a microphysiological human placental barrier model for studying placental drug transfer. Reproductive Toxicology. 123. 108523–108523. 2 indexed citations
6.
He, Xiaobo, Xiaoqing Guo, Matthew Bryant, et al.. (2022). Genotoxicity evaluation of nitrosamine impurities using human TK6 cells transduced with cytochrome P450s. Archives of Toxicology. 96(11). 3077–3089. 19 indexed citations
7.
Xiong, Rui, Qiangen Wu, Levan Muskhelishvili, et al.. (2018). Evaluating Mode of Action of Acrolein Toxicity in an In Vitro Human Airway Tissue Model. Toxicological Sciences. 166(2). 451–464. 33 indexed citations
8.
Qin, Qin, Qiangen Wu, Yiying Wang, et al.. (2018). Effects of cellular differentiation in human primary bronchial epithelial cells: Metabolism of 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone. Toxicology in Vitro. 55. 185–194. 8 indexed citations
9.
Chen, Si, Qiangen Wu, Baitang Ning, Matthew Bryant, & Lei Guo. (2018). The role of hepatic cytochrome P450s in the cytotoxicity of dronedarone. Archives of Toxicology. 92(6). 1969–1981. 12 indexed citations
10.
Zhang, Jun, Lijun Ren, Xi Yang, et al.. (2018). Cytotoxicity of 34 FDA approved small-molecule kinase inhibitors in primary rat and human hepatocytes. Toxicology Letters. 291. 138–148. 23 indexed citations
11.
Wu, Qiangen, Baitang Ning, Jiekun Xuan, et al.. (2016). The role of CYP 3A4 and 1A1 in amiodarone-induced hepatocellular toxicity. Toxicology Letters. 253. 55–62. 39 indexed citations
12.
Zhang, Jun, Alec T. Salminen, Xi Yang, et al.. (2016). Effects of 31 FDA approved small-molecule kinase inhibitors on isolated rat liver mitochondria. Archives of Toxicology. 91(8). 2921–2938. 74 indexed citations
13.
Camacho, Luísa, Sherry M. Lewis, Michelle M. Vanlandingham, et al.. (2016). Comparison of endpoints relevant to toxicity assessments in 3 generations of CD-1 mice fed irradiated natural and purified ingredient diets with varying soy protein and isoflavone contents. Food and Chemical Toxicology. 94. 39–56. 12 indexed citations
14.
Delclos, K. Barry, Luísa Camacho, Sherry M. Lewis, et al.. (2014). Toxicity Evaluation of Bisphenol A Administered by Gavage to Sprague Dawley Rats From Gestation Day 6 Through Postnatal Day 90. Toxicological Sciences. 139(1). 174–197. 132 indexed citations
15.
Chackalamannil, Samuel, Yan Xia, Keith Eagen, et al.. (2012). Discovery of nor-seco himbacine analogs as thrombin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 22(7). 2544–2549. 11 indexed citations
17.
Chackalamannil, Samuel, Yan Xia, William J. Greenlee, et al.. (2005). Discovery of Potent Orally Active Thrombin Receptor (Protease Activated Receptor 1) Antagonists as Novel Antithrombotic Agents. Journal of Medicinal Chemistry. 48(19). 5884–5887. 106 indexed citations
19.
Bryant, Matthew, et al.. (1994). 2,6-Dimethylaniline—hemoglobin adducts from lidocaine in humans. Carcinogenesis. 15(10). 2287–2290. 46 indexed citations
20.
Lin, Dongxin, Jackson O. Lay, Matthew Bryant, et al.. (1994). Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry.. Environmental Health Perspectives. 102(suppl 6). 11–16. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026